Sanofi (NASDAQ:SNY) Receives $62.67 Average PT from Brokerages

Sanofi (NASDAQ:SNY) has earned an average recommendation of “Moderate Buy” from the fourteen research firms that are currently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $62.6667.

SNY has been the subject of several recent analyst reports. Jefferies Financial Group restated a “buy” rating on shares of Sanofi in a research report on Monday, October 27th. Guggenheim lowered Sanofi from a “buy” rating to a “neutral” rating in a report on Tuesday, December 9th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sanofi in a research report on Friday. HSBC reiterated a “buy” rating on shares of Sanofi in a research report on Wednesday, December 10th. Finally, Cowen reissued a “hold” rating on shares of Sanofi in a report on Tuesday, December 30th.

Institutional Trading of Sanofi

A number of institutional investors have recently made changes to their positions in the stock. Financial Consulate Inc. acquired a new stake in Sanofi in the third quarter worth approximately $26,000. Ameritas Advisory Services LLC bought a new stake in shares of Sanofi in the 2nd quarter worth $28,000. Measured Wealth Private Client Group LLC bought a new stake in shares of Sanofi in the 3rd quarter worth $29,000. Palisade Asset Management LLC acquired a new stake in shares of Sanofi in the third quarter valued at $30,000. Finally, First Horizon Corp bought a new position in Sanofi during the third quarter valued at about $33,000. 14.03% of the stock is owned by institutional investors and hedge funds.

Sanofi Price Performance

Shares of SNY opened at $46.59 on Thursday. Sanofi has a 12 month low of $44.62 and a 12 month high of $60.12. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.06 and a quick ratio of 0.30. The stock has a fifty day moving average price of $49.00 and a 200 day moving average price of $48.84. The company has a market cap of $113.63 billion, a P/E ratio of 10.91, a PEG ratio of 1.16 and a beta of 0.45.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings results on Friday, October 24th. The company reported $2.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $1.31. The company had revenue of $15.46 billion during the quarter, compared to the consensus estimate of $12.62 billion. Sanofi had a net margin of 21.96% and a return on equity of 12.70%. The company’s revenue for the quarter was down 7.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.25 earnings per share. On average, research analysts forecast that Sanofi will post 4.36 earnings per share for the current year.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.